Michiko Nakamura1, Kimihiko Moriya2,3, Masafumi Kon1, Yoko Nishimura1, Hiroki Chiba1, Takeya Kitta1, Nobuo Shinohara1. 1. Department of Renal and Genitourinary Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan. 2. Department of Renal and Genitourinary Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan. k-moriya@med.hokudai.ac.jp. 3. Department of Urology, Sapporo City General Hospital, North-11, West-13, Chuo-Ku, Sapporo, 060-8604, Japan. k-moriya@med.hokudai.ac.jp.
Abstract
PURPOSE: To clarify the incidence of and risk factors for febrile urinary tract infection in children with persistent vesicoureteral reflux (VUR) after the discontinuation of continuous antibiotic prophylaxis (CAP), retrospective chart review was performed. PATIENTS AND METHODS: Among children with primary VUR at 10 years of age or younger at presentation, those who had persistent VUR despite conservative management with CAP and who were subsequently followed after discontinuation of CAP were included. Kaplan-Meier curve and Cox's proportional hazard regression model were used for evaluation of the incidence of and risk factors for febrile urinary tract infection (fUTI) after stopping CAP. RESULTS: Among 144 children (99 boys and 45 girls), fUTI developed in 34. The 5-year fUTI-free rate after discontinuation of CAP was 69.4%. On multivariate analyses, girls (p = 0.008) and abnormalities on nuclear renal scans (p = 0.0019), especially focal defect (p = 0.0471), were significant factors for fUTI. Although the fUTI-free rate was not different between children who had no or 1 risk factor, it was significantly lower in children with 2 risk factors than in those with no or 1 risk factor. CONCLUSIONS: The present study revealed that girls and abnormal renal scan, especially focal defect, are risk factors for fUTI. Active surveillance without CAP for persistent VUR seems to be a safe option for children with no or 1 risk factor. Prophylactic surgery or careful conservative follow-up may be an option for girls with abnormal renal scan results if VUR persists under CAP.
PURPOSE: To clarify the incidence of and risk factors for febrile urinary tract infection in children with persistent vesicoureteral reflux (VUR) after the discontinuation of continuous antibiotic prophylaxis (CAP), retrospective chart review was performed. PATIENTS AND METHODS: Among children with primary VUR at 10 years of age or younger at presentation, those who had persistent VUR despite conservative management with CAP and who were subsequently followed after discontinuation of CAP were included. Kaplan-Meier curve and Cox's proportional hazard regression model were used for evaluation of the incidence of and risk factors for febrile urinary tract infection (fUTI) after stopping CAP. RESULTS: Among 144 children (99 boys and 45 girls), fUTI developed in 34. The 5-year fUTI-free rate after discontinuation of CAP was 69.4%. On multivariate analyses, girls (p = 0.008) and abnormalities on nuclear renal scans (p = 0.0019), especially focal defect (p = 0.0471), were significant factors for fUTI. Although the fUTI-free rate was not different between children who had no or 1 risk factor, it was significantly lower in children with 2 risk factors than in those with no or 1 risk factor. CONCLUSIONS: The present study revealed that girls and abnormal renal scan, especially focal defect, are risk factors for fUTI. Active surveillance without CAP for persistent VUR seems to be a safe option for children with no or 1 risk factor. Prophylactic surgery or careful conservative follow-up may be an option for girls with abnormal renal scan results if VUR persists under CAP.
Authors: Carlos R Estrada; Carlo C Passerotti; Dionne A Graham; Craig A Peters; Stuart B Bauer; David A Diamond; Bartley G Cilento; Joseph G Borer; Marc Cendron; Caleb P Nelson; Richard S Lee; Jing Zhou; Alan B Retik; Hiep T Nguyen Journal: J Urol Date: 2009-08-15 Impact factor: 7.450
Authors: Alejandro Hoberman; Saul P Greenfield; Tej K Mattoo; Ron Keren; Ranjiv Mathews; Hans G Pohl; Bradley P Kropp; Steven J Skoog; Caleb P Nelson; Marva Moxey-Mims; Russell W Chesney; Myra A Carpenter Journal: N Engl J Med Date: 2014-05-04 Impact factor: 91.245
Authors: Craig A Peters; Steven J Skoog; Billy S Arant; Hillary L Copp; Jack S Elder; R Guy Hudson; Antoine E Khoury; Armando J Lorenzo; Hans G Pohl; Ellen Shapiro; Warren T Snodgrass; Mireya Diaz Journal: J Urol Date: 2010-07-21 Impact factor: 7.450
Authors: C William Schwab; Hsi-Yang Wu; Heather Selman; Grahame H H Smith; Howard M Snyder; Douglas A Canning Journal: J Urol Date: 2002-12 Impact factor: 7.450
Authors: Matthew J Knudson; J Christopher Austin; Zeb M McMillan; Charles E Hawtrey; Christopher S Cooper Journal: J Urol Date: 2007-08-17 Impact factor: 7.450